When did West Pharmaceutical Services report Q4 2024 earnings?

West Pharmaceutical Services (WST) reported Q4 2024 earnings on February 13, 2025 before market open.

What were West Pharmaceutical Services's Q4 2024 revenue and EPS?

West Pharmaceutical Services reported revenue of $748.8M and diluted EPS of $1.82 for Q4 2024.

Did West Pharmaceutical Services beat estimates in Q4 2024?

Revenue beat the consensus estimate of $740.5M by $8.3M. EPS beat the consensus estimate of $1.71 by $0.11.

Where can I find West Pharmaceutical Services's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000105770-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.

West Pharmaceutical Services WST Q4 2024 Annual earnings

Reported February 13, 2025 · Before market open

Revenue$748.8MBeat by $8.3M Diluted EPS$1.82Beat by $0.11

Revenue estimate$740.5M

EPS estimate$1.71

Next report

Jul 23, 2026 (In 1 week)

Revenue estimate$839.7M

EPS estimate$2.08

Financials

Q4 2024

Income statement

See full

Revenue$748.8M+2.3%

Gross profit$273.6M-1.7%

Operating income$159.6M-0.8%

Net income$130.1M-5.0%

EPS (diluted)$1.78-2.7%

Balance sheet

See full

Cash & equivalents$484.6M-43.2%

Total debt$305.3M-1.2%

Total equity$2.7B-6.9%

Total assets$3.6B-4.9%

Cash flow

See full

Operating cash flow$190.1M-20.5%

CapEx$104.9M-3.5%

Free cash flow$85.2M-34.7%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$23.72B-9.1%

Enterprise value$23.54B-7.8%

P/E48.1×+4.2×

P/S8.2×-0.6×

Profitability

See full

Gross margin34.5%-3.8pp

Operating margin19.7%-3.2pp

Net margin17%-3.1pp

FCF margin9.6%-4.5pp

Returns & leverage

See full

Return on equity17.7%-3.6pp

Debt / equity0.1×0.0×

Current ratio2.8×-0.1×

Segments

By segment

See full

Proprietary Products$613.9M+3.4%

Versus estimates

Revenue

Q1 2026$844.9MBeat by $64.6M Q4 2025$805.0MBeat by $10.1M Q3 2025$804.3MBeat by $18.6M Q2 2025$766.2MBeat by $40.1M Q1 2025$698.0MMiss by $15.0M

Q4 2024$748.8MBeat by $8.3M

Diluted EPS

Q1 2026$2.13Beat by $0.45 Q4 2025$2.04Beat by $0.21 Q3 2025$1.96Beat by $0.28 Q2 2025$1.84Beat by $0.33 Q1 2025$1.45Beat by $0.23

Q4 2024$1.82Beat by $0.11

Ask the moment West Pharmaceutical Services reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did West Pharmaceutical Services report Q4 2024 earnings?: West Pharmaceutical Services (WST) reported Q4 2024 earnings on February 13, 2025 before market open.
What were West Pharmaceutical Services's Q4 2024 revenue and EPS?: West Pharmaceutical Services reported revenue of $748.8M and diluted EPS of $1.82 for Q4 2024.
Did West Pharmaceutical Services beat estimates in Q4 2024?: Revenue beat the consensus estimate of $740.5M by $8.3M. EPS beat the consensus estimate of $1.71 by $0.11.
Where can I find West Pharmaceutical Services's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000105770-25-000013) directly on SEC EDGAR. The filing index links above go to sec.gov.